1 week Ago By ABMN Staff
Norges Bank acquired a new stake in LivaNova PLC ( NASDAQ:LIVN – Free Report ) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 84,750 shares of the company’s stock, valued at approximately $3,925,000. Norges Bank owned 0.
16% of LivaNova as of its most recent SEC filing. A number of other institutional investors also recently added to or reduced their stakes in the business. Artisan Partners Limited Partnership purchased a new position in shares of LivaNova in the 4th quarter valued at about $21,340,000.
Vanguard Group Inc. grew its position in LivaNova by 12.7% during the fourth quarter.
Vanguard Group Inc. now owns 2,349,887 shares of the company’s stock worth $108,823,000 after buying an additional 265,291 shares during the period. Raymond James Financial Inc.
acquired a new position in LivaNova during the fourth quarter worth about $9,645,000. JPMorgan Chase & Co. increased its holdings in LivaNova by 95.
7% in the fourth quarter. JPMorgan Chase & Co. now owns 387,772 shares of the company’s stock valued at $17,958,000 after buying an additional 189,665 shares in the last quarter.
Finally, Ruffer LLP acquired a new stake in shares of LivaNova during the 4th quarter valued at approximately $7,982,000. Hedge funds and other institutional investors own 97.64% of the company’s stock.
LivaNova Price Performance NASDAQ:LIVN opened at $34.14 on Friday. LivaNova PLC has a 12-month low of $32.
48 and a 12-month high of $64.48. The firm has a market cap of $1.
86 billion, a price-to-earnings ratio of 81.29 and a beta of 0.90.
The company’s 50-day moving average is $41.66 and its two-hundred day moving average is $47.44.
The company has a current ratio of 3.37, a quick ratio of 2.87 and a debt-to-equity ratio of 0.
46. Wall Street Analyst Weigh In Get Our Latest Report on LivaNova About LivaNova ( Free Report ) LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments.
The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. Further Reading Receive News & Ratings for LivaNova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LivaNova and related companies with MarketBeat.com's FREE daily email newsletter .
.
